Author

Eric Ngonga Kemadjou

Observed names: E NGONGA KEMADJOU, E. Kemadjou, Eric Kemadjou, Eric N. Kemadjou

Institution: F. Hoffmann-La Roche AG

Observed institution: F. Hoffmann-La Roche AG

OpenAlex ID: A5045501719

Updated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK

2020 · Omendra Narayan, Anthony Bentley, et al. · Journal of Medical Economics · 21

The Efficacy of Pediatric‐Inspired Regimens vs. Hyper‐ CVAD in the Treatment of Adolescents and Young Adults With Acute Lymphoblastic Leukemia: A Systematic Review and Meta‐Analysis

2025 · Wenqing Su, Melisa Stricherz, et al. · American Journal of Hematology · 8

Cost-Effectiveness of Defibrotide for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Multi-Organ Dysfunction (MOD) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Canada

2018 · Jonathan Belsey, Eric Ngonga Kemadjou, et al. · Blood · 2

Defibrotide Cost-Effectiveness in Canada for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Multi-Organ Dysfunction (MOD) after HSCT

2019 · Jonathan Belsey, Eric Ngonga Kemadjou, et al. · Transplantation and Cellular Therapy · 1

Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy

2026 · Chui-ying Yip, Eric N. Kemadjou, et al. · Journal of health economics and outcomes research

Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy

2026 · Chui-ying Yip, Eric Kemadjou, et al. · Journal of health economics and outcomes research

HTA14 Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy (DMD)

2024 · CY Yip, D Stewart, et al. · Value in Health

A Meta-Analysis Comparing the Relative Efficacy of Pediatric-Inspired Regimens Versus Hyper-CVAD for the Treatment of Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Adolescents, Young Adults, and Adults

2023 · Wenqing Su, Melisa Stricherz, et al. · Blood

A network meta-analysis of numbers needed to treat to prevent an episode of overt hepatic encephalopathy in patients with cirrhosis treated for at least 6 months with lactulose alone, or lactulose plus rifaximin-alpha

2022 · Juha Halonen, Roland Henrar, et al. · Journal of Hepatology

Post-randomization analysis of OS for patients who did not switch to second line targeted therapy in the TIVO-1 study

2016 · J. Belsey, E. Kemadjou · Annals of Oncology

Works count: 10

Citation count: 32

H-index: 2

I10-index: 1